Showing results (11-20 of 487) with videos related to
Sort By:
Pageof 49
Cancer Chemotherapy and Pharmacology|January 1, 1991
Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcomaB A Teicher, T S Herman, J Tanaka, et al.Cancer Chemotherapy and Pharmacology|January 1, 1989
Effect of lonidamine on the cytotoxicity of four alkylating agents in vitroK W Rosbe, T W Brann, S A Holden, et al.Cancer Research|November 15, 1988
Preclinical studies and clinical correlation of the effect of alkylating doseE Frei, B A Teicher, S A Holden, et al.International Journal of Cancer|June 19, 1991
Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivoJ Tanaka, B A Teicher, T S Herman, et al.Cancer Chemotherapy and Pharmacology|January 1, 1991
Combination of etanidazole with cyclophosphamide and platinum complexesB A Teicher, T S Herman, L Shulman, et al.Cancer Research|September 1, 1986
Alkylating agents: in vitro studies of cross-resistance patterns in human cell linesB A Teicher, C A Cucchi, J B Lee, et al.Cancer Research|February 1, 1991
Lonidamine as a modulator of alkylating agent activity in vitro and in vivoB A Teicher, T S Herman, S A Holden, et al.Cancer Research|February 1, 1989
Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agentsJ P Eder, B A Teicher, S A Holden, et al.Cancer Research|November 1, 1989
Influence of schedule on alkylating agent cytotoxicity in vitro and in vivoB A Teicher, S A Holden, J P Eder, et al.Seminars in Oncology|February 1, 1990
Preclinical studies relating to the use of thiotepa in the high-dose setting alone and in combinationB A Teicher, S A Holden, J P Eder, et al.Pageof 49